Author(s): Menuet M, Bittar F, Stremler N, Dubus JC, Sarles J,
Abstract Share this page
Abstract INTRODUCTION: Cystic fibrosis afflicted lungs support the growth of many bacteria rarely implicated in other cases of human infections. CASE PRESENTATION: We report the isolation and identification, by 16S rRNA amplification and sequencing, of two emerging pathogens resistant to colistin, Brevundimonas diminuta and Ochrobactrum anthropi, in a 17-year-old woman with cystic fibrosis and pneumonia. The patient eventually responded well to a 2-week regime of imipenem and tobramycin. CONCLUSION: Our results clearly re-emphasize the emergence of new colistin-resistant pathogens in patients with cystic fibrosis.
This article was published in J Med Case Rep
and referenced in Internal Medicine: Open Access